Atlas Trials

Durvalumab and "Booster" Radiation in Metastatic Adenocarcinoma of the Pancreas

Clinical trial NCT03490760 · TERMINATED

Trial details

NCT number
NCT03490760
Sponsor
Baptist Health South Florida
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Adenocarcinoma of the Pancreas
Start date
2018-11-09
Primary completion
2020-07-09
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.